Gonyautoxin 2/3

gonyautoxin 2/3 · Algenis SpA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gonyautoxin 2/3, covering 2021-03-16 to 2021-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study [Phase 1, Phase 2]